New York, NY -- (SBWIRE) -- 12/10/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Coronado Biosciences Inc (NASDAQ:CNDO), Orexigen Therapeutics, Inc (NASDAQ:OREX), Ford Motor Company (NYSE:F), Formcap Corp (OTCMKTS:FRMC)
Coronado Biosciences Inc (NASDAQ:CNDO) showed a volume of 3.84 million shares by the end of last trade whereas the average volume of the stock remained 1.22 million shares. The stock opened the session at $1.78 but then moved to $1.95. At that price, the stock showed a positive performance of 13.37%. Coronado Biosciences, Inc. is a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer. The Company’s two principal pharmaceutical product candidates in clinical development include Trichuris suis ova or CNDO-201 (TSO) a biologic comprising of the microscopic eggs of the porcine whipworm, for the treatment of autoimmune diseases, such as Crohn’s disease (Crohn’s), ulcerative colitis (UC) and multiple sclerosis (MS), and CNDO-109, a compound that activates natural killer (NK) cells of the immune system to seek and destroy cancer cells, for the treatment of acute myeloid leukemia (AML).
Will CNDO Continue To Move Higher? Find Out Here
Orexigen Therapeutics, Inc (NASDAQ:OREX) opened the session at $5.76 and closed the session at $5.71. The stock showed a negative performance of -0.35% in previous trading session. Traded with volume of 2.22 million shares in the prior session and the average volume of the stock remained 2.51 million shares. Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the body's efforts to compensate for weight loss.
Has OREX Found The Bottom And Ready To Gain Momentum? Find Out Here
Ford Motor Company (NYSE:F) opened the session at $16.68 and closed the session at $16.56. The stock showed a negative performance of -0.84% in previous trading session. Traded with volume of 34.38 million shares in the prior session and the average volume of the stock remained 36.45 million shares. The beta of the stock remained 2.25. Ford Motor Company (Ford) is a producer of automobiles. The Company together with its subsidiaries is engaged in other businesses, including financing vehicles. The Company operates in two segments: Automotive and Financial Services.
Why Should Investors Buy Ford After the Recent Fall? Just Go Here and Find Out
Formcap Corp (OTCMKTS:FRMC) the stock advanced 2.44% and finished the session at $1.26. Traded with volume of 488,587.00 shares in the prior session and the average volume of the stock remained 326,785.00 shares. The beta of the stock remained -2.97. FormCap Corp. (FormCap) is an exploration-stage company. The Company’s primary focus is the discovery and development of oil in the Continental United States. As of December 31, 2011, it assembled 4,800 acres of oil and gas mineral leases, the Weber City Prospect. The Company’s Weber City Prospect is located in Curry County, New Mexico. On February 15, 2011, the Company assigned all its rights in the leases to Rich Investments Ltd. (Rich) and Leare Developments Ltd.
Will FRMC Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)